United States — Food and Drug Administration & Medtronic
5 shared events · Importance 3 · Last updated Jun 05, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The FDA granted De Novo marketing authorization for J&J's OTTAVA system, clearing it for multiple general surgery procedures. This regulatory action enables J&J's commercial launch in the US.
Medtronic: Medtronic's Hugo robot, approved last year, now faces additional competition from J&J's OTTAVA system in the robotic surgery market.
Jul 22, 2026 · 20 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body to which CereVasc will submit a Premarket Approval (PMA) for its eShunt System, a critical step for commercialization in the US.
Medtronic: Medtronic participated in the Series C financing, showing its interest in CereVasc's eShunt System and potentially expanding its portfolio in neurological medical devices.
Jun 04, 2026 · 6 articles
Business
United States — Food and Drug Administration: RapidPulse plans to seek FDA approval for its system pending clinical data.
Medtronic: Medtronic co-led the round, gaining strategic access to innovative stroke technology.
Jul 16, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Medtronic interact across events, view sentiment trends, and discover connected entities.
Open Dashboard